You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloablative Treatment

Showing 1 - 25 of 1,001
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

Not yet recruiting
  • Sickle Cell Disease
  • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy, Oral Mucositis Trial in

Recruiting
  • Myeloablative Allogeneic Hematopoietic Cell Transplantation
  • +3 more
  • THOR LX2.3 with LED Lollipop
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 27, 2022

Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)

Recruiting
  • Acute Leukemia
  • +3 more
  • VIC- 1911
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

Active, not recruiting
  • Mycoses
  • +5 more
  • anti-thymocyte globulin
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Jun 16, 2022

Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

Not yet recruiting
  • Lymphoid Leukemia
  • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
  • Treg CD34+ HSPC (Orca-T)
  • Palo Alto, California
    Stanford Cancer Center
Aug 17, 2022

Intravenous Busulfan And Fludarabine Myeloablative Conditioning

Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    Mar 16, 2022

    Predict T Cell Chimerism After MSD SCT for SCD?

    Recruiting
    • Sickle Cell Disease
    • Alemtuzumab Injection [Campath]
    • Amsterdam, Netherlands
      Amsterdam Medical Centre
    Jun 20, 2023

    Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

    Active, not recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Fludarabine + Total Marrow Irradiation
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jun 1, 2022

    Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • Haploidentical hematopoietic cell transplantation (haploHCT)
    • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
    • (no location specified)
    Jul 13, 2022

    Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

    Active, not recruiting
    • Sickle Cell Disease
    • Hemoglobinopathies
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Dec 20, 2021

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    Has Results
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

    Terminated
    • Acute Myeloid Leukemia
    • +3 more
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Feb 22, 2022

    Stem Cell Transplantation, Rehabilitation Trial in Aarhus (Multimodal interdisciplinary rehabilitation programme (HAPPY))

    Completed
    • Stem Cell Transplantation
    • Rehabilitation
    • Multimodal interdisciplinary rehabilitation programme (HAPPY)
    • Aarhus, Denmark
      Dep. of Hem. Aarhus Universitetshospital
    Nov 2, 2021

    Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,

    Completed
    Has Results
    • Myeloablative Conditioning
    • +3 more
    • Aurora, Colorado
    • +8 more
    Nov 23, 2021

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)

    Completed
    Has Results
    • Adult Lymphoblastic Lymphoma
    • Birmingham, Alabama
      UAB Bone Marrow Transplantation and Cellular Therapy Program
    Aug 23, 2022

    Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)

    Recruiting
    • Kidney Transplantation
    • TCD601
    • San Francisco, California
    • +4 more
    Oct 28, 2022

    Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

    Completed
    • Leukemia
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Sep 16, 2021

    Oral Mucositis Trial in Charlotte (Virgin Coconut Oil)

    Not yet recruiting
    • Oral Mucositis
    • Virgin Coconut Oil
    • Charlotte, North Carolina
      Atrium Health Levine Children's Hospital
    Aug 5, 2022

    Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

    Completed
    • Pleural Mesothelioma
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023